Baker Bros. Advisors Lp

13F Holdings History for Neurogene Inc. - Common Stock (NGNE)

Symbol: NGNE on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 992K shares
Security Ownership: 7%

Shares, Excluding Options vs Price

Value, Excluding Options

Julian C. Baker ownership in Neurogene Inc. Common Stock (NGNE)

2025-08-14 - Julian C. Baker has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 992K shares of Neurogene Inc. Common Stock (NGNE). This represents 7% percent ownership of the company. In their previous filing dated 2025-05-15, BAKER BROS. ADVISORS LP had reported owning 1.49M shares, indicating a decrease of -33.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Julian C. Baker	7%	-29.6%	$18.7M	992K	-494,509	-33.3%	$18.84	13G/A	6/30/2025	14 Aug 2025 16:27:25
Julian C. Baker	9.96%		$16.3M	1.49M			$11.00	13G	3/31/2025	15 May 2025 16:19:38

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.12%		$17.2M	992K			$17.33	Q3 2025
6/30/2025	0.14%	-0.07%	$14.8M	992K	-494,509	-33.3%	$14.95	Q2 2025
3/31/2025	0.19%	+0.11%	$17.4M	1.49M	+811,750	+100%	$11.71	Q1 2025
12/31/2024	0.16%	+0.05%	$15.4M	674K	+218,435	+47.9%	$22.86	Q4 2024
9/30/2024	0.2%		$19.1M	456K			$41.96	Q3 2024
6/30/2024	0.21%		$16.6M	456K			$36.39	Q2 2024
3/31/2024	0.29%	+0%	$23.2M	456K	+2,499	+0.55%	$50.90	Q1 2024
12/31/2023	0.1%	+0.05%	$8.79M	454K	+453,516	NEW	$19.38	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.